Interleukin-4 (IL-4) inhibits activation of cyclooxygenase-II (COX-II) expression in intestinal myofibroblasts.

被引：0
|
作者：
Valentich, JD [1 ]
Saada, JI [1 ]
Powell, DW [1 ]
机构：
[1] UNIV TEXAS, MED BRANCH, GALVESTON, TX 77555 USA
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1109 / A1109
页数：1
相关论文
共 50 条
  • [41] INTERLEUKIN-1 TYPE-II RECEPTOR - A DECOY TARGET FOR IL-1 THAT IS REGULATED BY IL-4
    COLOTTA, F
    RE, F
    MUZIO, M
    BERTINI, R
    POLENTARUTTI, N
    SIRONI, M
    GIRI, JG
    DOWER, SK
    SIMS, JE
    MANTOVANI, A
    SCIENCE, 1993, 261 (5120) : 472 - 475
  • [42] Regulation of the Receptor Activator of NF-κB Ligand (RANKL)-induced activation of the alternative NF-κB pathways by interleukin-4 (IL-4)
    Yu, Minjun
    Moreno, Jose
    Keegan, Achsah
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [43] INTERLEUKIN-8 (IL-8) INHIBITS THE INTERLEUKIN-4 (IL-4)-INDUCED BUT NOT THE SPONTANEOUS GROWTH OF HUMAN B-CELLS VIA MECHANISMS THAT MAY INVOLVE PROTEIN-KINASE-C
    KIMATA, H
    FUJIMOTO, M
    LINDLEY, I
    FURUSHO, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 207 (03) : 1044 - 1050
  • [44] EVALUATION OF MURINE INTERLEUKIN-4 (IL-4) RECEPTOR EXPRESSION USING ANTIRECEPTOR MONOCLONAL-ANTIBODIES AND S1 NUCLEASE PROTECTION ANALYSES
    ISHIDA, H
    YANG, G
    HARADA, N
    HASTINGS, RL
    CASTLE, BE
    KASTELEIN, R
    MIYAJIMA, A
    HOWARD, M
    CELLULAR IMMUNOLOGY, 1991, 136 (01) : 142 - 154
  • [45] RELATIONSHIPS BETWEEN NF-KAPPA-B AND DNA-BINDING PROTEIN(S) FOR THE HUMAN INTERLEUKIN-4 (IL-4) GENE-EXPRESSION
    MATSUDA, I
    TSUBOI, A
    ARAI, K
    ARAI, N
    FASEB JOURNAL, 1992, 6 (04): : A1331 - A1331
  • [46] OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4+ T cells into high IL-4-producing effectors
    Ohshima, Y
    Yang, LP
    Uchiyama, T
    Tanaka, Y
    Baum, P
    Sergerie, M
    Hermann, P
    Delespesse, G
    BLOOD, 1998, 92 (09) : 3338 - 3345
  • [47] FTY-720P Suppresses Osteoclast Formation by Regulating Expression of Interleukin-6 (IL-6), Interleukin-4 (IL-4), and Matrix Metalloproteinase 2 (MMP-2)
    Zhang, Dawei
    Huang, Yongjun
    Huang, Zongwen
    Zhang, Rongkai
    Wang, Honggang
    Huang, Dong
    MEDICAL SCIENCE MONITOR, 2016, 22 : 2187 - 2194
  • [48] EXPRESSION OF CLASS-II MHC (IA) ANTIGENS ON MURINE INTESTINAL EPITHELIAL-CELLS IS INCREASED BY SYSTEMIC ADMINISTRATION OF IL-4
    FUJIYAMA, Y
    OHARA, J
    LEE, E
    HAMADA, T
    BROWN, WR
    FASEB JOURNAL, 1991, 5 (05): : A967 - A967
  • [49] Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51
    Kurtz, David M.
    Tschetter, Loren K.
    Allred, Jacob B.
    Geyer, Susan M.
    Kurtin, Paul J.
    Putnam, Wesley D.
    Rowland, Kendrith M., Jr.
    Wiesenfeld, Martin
    Soori, Gamini S.
    Tenglin, Richard C.
    Bernath, Albert M.
    Witzig, Thomas E.
    LEUKEMIA & LYMPHOMA, 2007, 48 (07) : 1290 - 1298
  • [50] SYNERGISM OF GLUCOCORTICOIDS WITH GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR (GM-CSF) BUT NOT INTERFERON-GAMMA (IFN-GAMMA) OR INTERLEUKIN-4 (IL-4) ON INDUCTION OF HLA CLASS-II EXPRESSION ON HUMAN MONOCYTES
    SADEGHI, R
    HAWRYLOWICZ, CM
    CHERNAJOVSKY, Y
    FELDMANN, M
    CYTOKINE, 1992, 4 (04) : 287 - 297
12345